Literature DB >> 34116630

Prevalence and risk factors of atrioventricular block among 15 million Chinese health examination participants in 2018: a nation-wide cross-sectional study.

Ruiqi Shan1, Yi Ning2,3, Yuan Ma4, Siliang Liu5, Jing Wu1, Xiaohan Fan6, Jun Lv1,7,8, Bo Wang7,4, Shijun Li4, Liming Li9,10,11.   

Abstract

BACKGROUND: Nationwide data on the prevalence of atrioventricular (AV) block are currently unavailable in China. Thus, we aimed to assess the prevalence and risk factors of AV block among Chinese health examination adults.
METHODS: A total of 15,181,402 participants aged ≥ 18 years (mean age 41.5 ± 13.4 years, 53.2% men) who underwent an electrocardiogram as a part of routine health examination in 2018 were analyzed. AV block was diagnosed by physicians using 12-lead electrocardiogram. Overall and stratified prevalence (by age, sex, and city size) of all, first-, second- and third-degree AV block were calculated. Multivariable logistic regression analyses were performed to explore risk factors associated with AV block.
RESULTS: AV block was observed in 88,842 participants, including 86,153 with first-degree, 2249 with second-degree and 440 with third-degree AV block. The age- and sex-standardized prevalence rate [95% confidence interval (CI)] of all, first-, second- and third-degree AV block were 7.06‰ (7.01-7.11), 6.84‰ (6.79-6.89), 0.18‰ (0.17-0.18) and 0.04‰ (0.03-0.04) respectively. After multivariable adjustment, the risk of AV block was positively associated with older age, being male, lower heart rate, higher body mass index, hypertension, diabetes and low high-density lipoprotein cholesterol. High total cholesterol was associated with a lower risk of AV block.
CONCLUSION: First-degree AV block is relatively common while severe AV block is rare in health examination adults. Besides, AV block was highly prevalent among the elderly. The risk of AV block was associated with older age, being male and metabolic factors.

Entities:  

Keywords:  Atrioventricular block; China; Epidemiology; Prevalence; Risk factor

Year:  2021        PMID: 34116630     DOI: 10.1186/s12872-021-02105-3

Source DB:  PubMed          Journal:  BMC Cardiovasc Disord        ISSN: 1471-2261            Impact factor:   2.298


  1 in total

1.  Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe).

Authors:  Christina Magnussen; Teemu J Niiranen; Francisco M Ojeda; Francesco Gianfagna; Stefan Blankenberg; Inger Njølstad; Erkki Vartiainen; Susana Sans; Gerard Pasterkamp; Maria Hughes; Simona Costanzo; Maria Benedetta Donati; Pekka Jousilahti; Allan Linneberg; Tarja Palosaari; Giovanni de Gaetano; Martin Bobak; Hester M den Ruijter; Ellisiv Mathiesen; Torben Jørgensen; Stefan Söderberg; Kari Kuulasmaa; Tanja Zeller; Licia Iacoviello; Veikko Salomaa; Renate B Schnabel
Journal:  Circulation       Date:  2017-10-16       Impact factor: 29.690

  1 in total
  3 in total

1.  Prevalence and Risk for Bundle Branch Block, Atrioventricular Block and Pacemaker Implantation in Spondyloarthritis. A Systematic Review of the Literature.

Authors:  Hye Sang Park; Ana Laiz; Petra Díaz Del Campo; María A Martín Martínez; M Guerra-Rodriguez; Concepcion Alonso-Martin; Jesus Sanchez-Vega; Hector Corominas
Journal:  Front Med (Lausanne)       Date:  2022-03-25

2.  Elimination of Vitamin D Signaling Causes Increased Mortality in a Model of Overactivation of the Insulin Receptor: Role of Lipid Metabolism.

Authors:  Maria Crespo-Masip; Aurora Perez-Gomez; Alicia Garcia-Carrasco; Ramiro Jover; Carla Guzmán; Xavier Dolcet; Mercé Ibarz; Cristina Martínez; Àuria Eritja; Juan Miguel Diaz-Tocados; José Manuel Valdivielso
Journal:  Nutrients       Date:  2022-04-05       Impact factor: 5.717

3.  Sex differences in rates of permanent pacemaker implantation and in-hospital complications: A statewide cohort study of over 7 million persons from 2009-2018.

Authors:  Vijayatubini Vijayarajan; Leonard Kritharides; David Brieger; Yeu-Yao Cheng; Vincent Chow; Austin Chin Chwan Ng
Journal:  PLoS One       Date:  2022-08-10       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.